Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 74Lung Neoplasms 35Adenocarcinoma of Lung 6Pancoast Syndrome 2NSCLC 2Mesothelioma, Malignant 2Carcinoma 2Unresectable Non-small Cell Lung Cancer 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1SCLC, Limited Stage 1Respiratory Aspiration 1Resectable Non-small Cell Lung Cancer 1Pulmonary Disease, Chronic Obstructive 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Peritoneal Neoplasms 1Pathologic Complete Response 1Ovarian Neoplasms 1Mesothelioma 1Locally Advanced Non-Small Cell Lung Cancer 1Limited Stage Small Cell Lung Cancer 1II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer 1Esophageal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Acute Kidney Injury 1

Interventions

Pemetrexed 14Carboplatin 13osimertinib 11aflutinib 9Drug Therapy 9Gefitinib 8Radiotherapy 6Docetaxel 6Cisplatin 6pembrolizumab 5anlotinib 5Radiosurgery 5Paclitaxel 5icotinib 4Vinorelbine 4Gemcitabine 4Erlotinib Hydrochloride 4tislelizumab 3camrelizumab 3apatinib 3HM781-36B 3toripalimab 2spartalizumab 2rezivertinib 2dacomitinib 2Tyrosine Kinase Inhibitors 2Thalidomide 2Surgical Procedures, Operative 2S 1 (combination) 2Platinum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NSCLC × Surgical Procedures, Operative × Thoracic × Clear all
NCT07089199 2025-07-28

TitAN

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting
34 enrolled
Thoracic

NSCLC

NCT06944470 2025-04-25

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Shanghai Junshi Bioscience Co., Ltd.

Phase 2 Not yet recruiting
76 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡